Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Chryseobacterium formosense strain:LMG 24722

ABSTRACT: Chryseobacterium formosense LMG 24722 Genome sequencing

PROVIDER: PRJNA256039 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	SRR28462898_1.fastq.gz	Fastqsanger.gz
	SRR28462898_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 3 of 3

Similar Datasets

Chryseobacterium formosense

Project description:Chryseobacterium formosense overview

| PRJNA330565 | ENA

Chryseobacterium formosense strain:DSM 17452 | isolate:DSM 17452

Project description:Chryseobacterium formosense DSM 17452 genome sequencing

| PRJNA329825 | ENA

Chryseobacterium vrystaatense strain:LMG 22846

Project description:Chryseobacterium vrystaatense strain:LMG 22846 Genome sequencing and assembly

| PRJNA255945 | ENA

Analysis of differential gene expression in the degradation of doxycycline by Chryseobacterium sp. WX1

Project description:We isolated an efficient doxycycline degrading strain Chryseobacterium sp. WX1. To investigate gene expression patterns during doxycyclinedegradation by strain WX1, we conducted a comparative transcriptomic analysis using cultures of strain WX1 with and without doxycycline addition. The RNA-Seq data revealed that 90.44-96.56% of the reads mapped to the genome of Chryseobacterium sp. WX1 across all samples. Differentially expressed genes (DEGs) analysis (|log2FC| >2; p < 0.01) showed that 693 genes were significantly up-regulated and 592 genes were significantly down-regulated.

2023-09-12 | GSE242785 | GEO

Azospirillum formosense

Project description:Azospirillum formosense overview

| PRJNA734414 | ENA

Azospirillum formosense strain:Nfb7

Project description:Azospirillum formosense strain:Nfb7 Genome sequencing and assembly

| PRJNA630591 | ENA

Azospirillum formosense strain:UWAZO-1

Project description:Azospirillum formosense strain:UWAZO-1 Genome sequencing

| PRJNA1128128 | ENA

Transcriptome profiling reveals the EanI/R quorum sensing regulon in Pantoea ananatis LMG 2665T

Project description:Background: Pantoea ananatis LMG 2665T synthesizes and utilizes acyl homoserine lactones (AHLs) for signaling. In this strain, short chain AHLs (C4 to C8) are produced by the EanI/R quorum sensing (QS) system that is involved in pathogenicity and biofilm formation. The complete set of genes regulated by the EanI/R system in P. ananatis LMG 2665T is still not fully known. In the present study, RNA-seq was used to analyze the transcriptome profiles controlled by the EanI/R system in this strain by comparing the wild type strain and its QS mutant 2665T ean∆I/R during lag and log stages. The RNA seq data was validated by RT qPCR. Results: The results showed that the EanI/R regulon in P. ananatis LMG 2665T comprised 144 genes, constituting 3.3% of the whole transcriptome under the experimental conditions in this study. The majority of genes regulated by the EanI/R system included genes for flagella assembly, bacterial chemotaxis, pyruvate metabolism, two component system, metabolic pathways, microbial metabolism and biosynthesis of secondary metabolites. Conclusions: This is the first study to identify the EanI/R QS regulon in P. ananatis LMG 2665T. Functional analysis of genes regulated the EanI/R system in LMG 2665T could help unveil genes that play a vital role in pathogenesis and survival strategies of this pathogen.

2018-10-31 | GSE87207 | GEO

Azospirillum formosense strain:CC-NFb-7

Project description:Azospirillum formosense strain:CC-NFb-7 Genome sequencing and assembly

| PRJNA577424 | ENA

Proteomic data on the biodegradation of doxycycline by Chryseobacterium sp. WX1

Project description:In this study, we isolated a potent doxycycline-degrading bacterium, Chryseobacterium sp. WX1, from environmental samples. To elucidate the molecular mechanisms underlying doxycycline degradation by strain WX1, we assessed and interpreted the proteomic profiles of Chryseobacterium sp. WX1 under conditions both with and without doxycycline exposure.

2023-09-07 | PXD045182 | Pride

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data